Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAPC.L Share News (CAPC)

  • There is currently no data for CAPC

Friday broker round-up UPDATE

Fri, 12th Jul 2013 08:11
Ashmore Group: Morgan Stanley cuts target price from 444p to 420p and leaves its equal-weight rating unchanged. JP Morgan ups target price from 339p to 377p maintaining a neutral rating.AstraZeneca: Jefferies reduces target price from 3560p to 3400p, while keeping its hold recommendation.Aviva: Nomura cuts target price from 540p to 414p, while its buy recommendation remains unchanged.Balfour Beatty: RBC Capital cuts target price from 220p to 200p and stays with a neutral rating.Barclays: Exane lowers target price from 400p to 380p and retains an outperform rating. Numis downgrades to reduce with a target price of 272p.Bellway: Panmure Gordon raises target price from 1076p to 1327p, while keeping a hold recommendation.British Land: Exane shifts target price from 600p to 590p maintaining a neutral rating.Burberry: Credit Suisse raises target price from 1600p to 1700p and reiterates an outperform rating.Capital & Counties Properties: Exane shifts target price from 414p to 415p retaining an outperform rating.Derwent London: Exane takes target price from 2220p to 2300p and reiterates a neutral rating.G4S: Deutsche Bank moves target price from 250p to 212p leaving its hold recommendation unchanged. Exane cuts target price from 280p to 240p staying with its neutral rating.Hammerson: Exane lowers target price from 600p to 580p reiterating its outperform rating.Hays: Credit Suisse ups target price from 99p to 110p and retains an outperform rating. JP Morgan moves target price from 90.40p to 102p, while its neutral rating remains unchanged.Intu Properties: Exane reduces target price from 330p to 300p downgrading to underperform.Kirkland Lake Gold: Investec lowers target price from 396p to 380p, while staying with its buy recommendation.Land Securities: Exane moves target price from 940p to 930p keeping a neutral rating.Legal & General: Nomura shifts target price from 185p to 188p, while downgrading from buy to neutral.Mothercare: Panmure Gordon ups target price from 280p to 420p and upgrades from sell to hold.Premier Oil: Deutsche Bank shifts target rice from 560p to 566p and keeps a buy recommendation.Prudential: Nomura increases target price from 680p to 1392p upgrading from reduce to buy.Reckitt Benckiser: Nomura cuts target price from 4900p to 4800p, while leaving its buy recommendation unaltered. Credit Suisse reduces target price from 4900p to 4650p keeping a neutral rating.Resolution: Nomura takes target price from 250p to 311p upgrading from reduce to neutral.Robert Walters: Investec ups target price from 235p to 248p and keeps a buy recommendation. Panmure Gordon ups target price from 144p to 172p, but still recommends selling.SAB Miller: Jefferies raises target price from 3200p to 3680p and maintains a buy recommendation.Segro: Exane ups target price from 260p to 270p keeping an underperform rating.Serco Group: Deutsche Bank ups target price from 600p to 630p and reiterates a hold recommendation.Standard Life: Nomura moves target price from 260p to 351p, but reiterates a reduce rating.St James's Place: Nomura ups target price from 370p to 668p and upgrades from neutral to buy.Versarien: Westhouse Securities initiates with a target price of 20p and a buy recommendation.

Related News

GLOBAL MARKETS-Stocks dip after US-Iran peace talks delay; yen nears 40-year lows 
1 day ago

GLOBAL MARKETS-Stocks dip after US-Iran peace talks delay; yen nears 40-year lows 

* Vance pulls out of Friday talks with Iran, oil erases earlier losses

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses
1 day ago

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Moderna's mRNA flu vaccine backed by FDA advisers
1 day ago

Moderna's mRNA flu vaccine backed by FDA advisers

* ⁠FDA advisers back mFlusiva's benefits for adults 50 and up

CAPC.L News

REPEAT: Capco to rename to Shaftesbury Capital after merger
3 Mar 2023

REPEAT: Capco to rename to Shaftesbury Capital after merger

Capital & Counties Properties PLC - London-based property investment and development company - Will change of name to Shaftesbury Capital PLC followin...

Shaftesbury and Capital & Counties merger scheme implemented
2 Mar 2023

Shaftesbury and Capital & Counties merger scheme implemented

(Alliance News) - Shaftesbury PLC on Thursday announced the scheme for its all-share merger with Capital & Counties Properties PLC is being implemente...

SThree to replace Shaftesbury in the FTSE 250 following merger
1 Mar 2023

SThree to replace Shaftesbury in the FTSE 250 following merger

(Alliance News) - FTSE Russell said on Wednesday that SThree PLC will be added to the FTSE 250 index, replacing Shaftesbury PLC which is being removed...

Capital & Counties focuses on Shaftesbury merger after annual loss
1 Mar 2023

Capital & Counties focuses on Shaftesbury merger after annual loss

(Alliance News) - Capital & Counties Properties PLC on Wednesday said there was strong momentum ahead of the completion of its all-share merger with S...

Capital & Counties slides as it swings to loss
1 Mar 2023

Capital & Counties slides as it swings to loss

(Sharecast News) - Capital & Counties reported a mixed year in its final results on Wednesday, with underlying net rental income increasing to £5...

Shaftesbury and Capco hail UK CMA decision to approve all-share merger
22 Feb 2023

Shaftesbury and Capco hail UK CMA decision to approve all-share merger

(Alliance News) - Capital & Counties Properties PLC and Shaftesbury PLC on Wednesday welcomed the UK Competition & Markets Authority's decision not to...